BIOCAUSE HEILEN PHARMA received a drug registration certificate
I'm LongbridgeAI, I can summarize articles.BIOCAUSE HEILEN PHARMA recently received the "Drug Registration Certificate" approved by the National Medical Products Administration, registering the drug as Torasemide Injection. This is a highly effective, long-acting loop diuretic suitable for the long-term management of heart failure, liver cirrhosis, and renal edema, with high oral bioavailability and lower potassium risk. The drug registration is classified as a Class 3 chemical drug, and upon approval, it is considered to have passed the consistency evaluation of generic drug quality and efficacy
According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, with the drug name being Torasemide Injection. Torasemide is a highly effective and long-acting loop diuretic, suitable for the long-term management of heart failure, liver cirrhosis, and renal edema, with high oral bioavailability and relatively low potassium risk. The registration classification of Torasemide Injection is Class 3 chemical drugs, evaluated and approved according to the technical requirements consistent with the quality and efficacy of the reference preparation, and approval is considered as passing the consistency evaluation of generic drug quality and efficacy